Christian Schneider

Chief Executive Officer at

Schneider Schreibgeräte Gmbh

Health Technology

Commercial Services

Consumer Services

Profile

Dr. Christian Schneider is a Managing Partner at Vesalius Biocapital Partners SARL, a Co-Managing Director at Schneider Schreibgeräte Gmbh and a Principal at Vectura GmbH.
He is on the Board of Directors at Trod Medical NV and Ventaleon GmbH.
Dr. Schneider was previously employed as a Managing Partner by PolyTechnos Venture-Partners II GmbH, a Manager-External Research by Centocor, Inc., a Principal by Roche Diagnostics GmbH, an Independent Director by Advitos GmbH, a Director-Executive Board by AplaGen GmbH, and an Independent Director by MagnaMedics GmbH.
He also served on the board at deVGen NV, Humedics GmbH, OncoMethylome Sciences SA and Shire Orphan Therapies GmbH.
He received his MBA from Penn State Great Valley and a doctorate degree from Ludwig-Maximilians-Universität München.

Christian Schneider active positions

Companies	Position	Start
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Private Equity Investor	01/01/2008
Schneider Schreibgeräte Gmbh Schneider Schreibgeräte Gmbh Industrial ConglomeratesProducer Manufacturing Engages in manufacturing of products	Chief Executive Officer	-
Trod Medical NV Trod Medical NV Medical SpecialtiesHealth Technology Develops and commercializes tools for use in the focal ablation of soft tissues	Director/Board Member	-

All active positions of Christian Schneider

Former positions of Christian Schneider

Companies	Position	End
MDXHEALTH SA	Director/Board Member	23/01/2009
PolyTechnos Venture-Partners GmbH PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields.	Private Equity Investor	05/11/2007
Centocor, Inc. Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products	Corporate Officer/Principal	-
Roche Diagnostics GmbH Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics	Corporate Officer/Principal	-
MagnaMedics GmbH MagnaMedics GmbH Medical SpecialtiesHealth Technology Develops and markets biological diagnostic products	Director/Board Member	-

See the detail of Christian Schneider's experience

Training of Christian Schneider

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christian Schneider's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Centocor, Inc. Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products	Health Technology
MDxHealth SA MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment	Health Technology
Shire Orphan Therapies GmbH Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs	Health Technology
Roche Diagnostics GmbH Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics	Commercial Services
deVGen NV deVGen NV BiotechnologyHealth Technology Provides biotechnology services for the pharmaceutical and agrochemical industries	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trod Medical NV Trod Medical NV Medical SpecialtiesHealth Technology Develops and commercializes tools for use in the focal ablation of soft tissues	Health Technology
MagnaMedics GmbH MagnaMedics GmbH Medical SpecialtiesHealth Technology Develops and markets biological diagnostic products	Health Technology
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Finance
AplaGen GmbH AplaGen GmbH BiotechnologyHealth Technology Develops and markets therapeutic peptides	Health Technology
Vectura GmbH Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems	Commercial Services
PolyTechnos Venture-Partners GmbH PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields.	Finance
Advitos GmbH Advitos GmbH Medical SpecialtiesHealth Technology Develops and commercializes liver support therapy devices	Health Technology
Schneider Schreibgeräte Gmbh Schneider Schreibgeräte Gmbh Industrial ConglomeratesProducer Manufacturing Engages in manufacturing of products	Producer Manufacturing
Humedics GmbH Humedics GmbH Packaged SoftwareTechnology Services Develops diagnostic systems technology for assessment of liver diseases	Technology Services
Ventaleon GmbH Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation	Health Technology
Penn State Great Valley Penn State Great Valley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services